Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2016

View Archived Issues

drNPCs to treat neurological disorders

SPR-741 potentiates antibiotics against multidrug-resistant Gram-negative infections

FDA approves Abbott's Absorb absorbable stent for coronary heart disease

Arbutus Biopharma issues notice of termination to NeuroVive for NVP-018

FDA grants orphan drug designation for iBio-CFB03

Oryzon Genomics selects LSD1 inhibitor for preclinical development

Aviragen to license, develop and commercialize RSV inhibitors

Midostaurin shows promising clinical results for advanced systemic mastocytosis

Actelion initiates phase III TOMORROW study to evaluate macitentan in children with PAH

FDA grants fast track status to Merrimack's seribantumab

Takeda receives E.U. marketing authorization for Adcetris in third indication

Vertex, Moderna sign exclusive collaboration agreement for development of mRNA therapeutics for CF

Tolerogenic nanoparticles suppress spontaneous development of T1D in NOD mice

Bio-Techne to acquire Advanced Cell Diagnostics

ADT Pharmaceuticals announces RAS Gtpase inhibitors

Merck & Co. patents orexin receptor inhibitors

Roche and Genentech report ERalpha antagonists and destabilizers

Shanghai Haiyan Pharmaceutical Technology and Yangtze River Pharmaceutical disclose PI3K inhibitors

Celgene divulges ERK inhibitors

Alios BioPharma patents NS5B inhibitors

Revestive approved in Europe for pediatric patients with short bowel syndrome

Medivation enters confidentiality agreements with Sanofi and other companies

Amicus obtains rights to preclinical CDKL5 program through acquisition of MiaMed

FDA accepts Revive's IND for a phase II trial of bucillamine for cystinuria

New PREVAIL trial opens in Liberia for men with Ebola virus RNA detected in semen

Nanobiotix reports results for phase I/II trial of NBTXR-3

Asuragen launches AmplideX PCR/CE C9orf72 Kit

RHOA, CSNK1A1, DVL2, FZD8 and LRP5 may be useful as poor prognosis biomarkers in GC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...